Innodem Neurosciences
Latest round
- Series A
Last raised
- Jan 2021
Total raised
- $6M
Investors
- 1
About Innodem Neurosciences
Founded in 2016 in Montreal, Canada, Innodem Neurosciences focuses on pioneering digital biomarkers for neurological assessments.Innodem Neurosciences specializes in digital biomarkers and artificial intelligence solutions, with its flagship product being the Eye Tracking Neurological Assessment, ETNA™. This innovative technology utilizes eye-tracking algorithms to provide quantitative measures of cognitive function and neurological health, specifically targeting various neurodegenerative and mental diseases such as multiple sclerosis, Parkinson’s disease, Alzheimer's disease, Friedreich Ataxia, and cancer-related cognitive impairment. The ETNA™ technology has undergone regulatory review and is being trialed with patients to enhance diagnostic accuracy and disease tracking capabilities. Innodem's services are designed for healthcare providers, research institutions, and pharmaceutical companies, with an emphasis on improving patient assessments and outcomes.Innodem Neurosciences generates revenue through partnerships and B2B transactions centered around its proprietary technology, ETNA™. The company collaborates with healthcare providers, research institutions, and pharmaceutical companies, facilitating access to advanced neurological assessments. Transactions typically involve agreements for the use of ETNA™ in clinical settings, where institutions may pay fees for software licenses or per-use assessments as part of their patient evaluation processes. The commercial transaction structure includes subscription models or one-time fees associated with the deployment of the ETNA™ technology in clinical trials and ongoing patient monitoring. The company is focused on enhancing its product offerings and will be launching new features for ETNA™ aimed at increasing diagnostic capabilities.
Who invested in Innodem Neurosciences
1 investor across 1 round
See all investors in Innodem Neurosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 19, 2021
Amount
$6M
Investors
Questions about Innodem Neurosciences
Who invested in Innodem Neurosciences?
Innodem Neurosciences has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Innodem Neurosciences raised?
Innodem Neurosciences has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Innodem Neurosciences last raise money?
Innodem Neurosciences's most recent round on record is a Series A, in Jan 2021.
What does Innodem Neurosciences do?
Founded in 2016 in Montreal, Canada, Innodem Neurosciences focuses on pioneering digital biomarkers for neurological assessments.
Where is Innodem Neurosciences headquartered?
Innodem Neurosciences is headquartered in Montreal, Canada.
Which VCs invest in companies like Innodem Neurosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Innodem Neurosciences's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Innodem Neurosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.